Angiodynamics, inc. (ANGO) 2026Q2 financial report shows revenue of 79.43M USD, with a YoY growth rate of 9.04%. This figure indicates that Angiodynamics, inc. (ANGO)’s operational performance has remained fundamentally stable. The moderate growth rate reflects a relatively steady market environment. Investors are advised to continuously and closely monitor the company’s future quarterly financial performance and key strategic adjustments. For a more comprehensive and objective assessment of Angiodynamics, inc. (ANGO)’s future growth potential and investment opportunities, it is recommended to incorporate Growin AI Value Analysis for a thorough and prudent evaluation.